spironolactone has been researched along with ru 28318 in 85 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (15.29) | 18.7374 |
1990's | 43 (50.59) | 18.2507 |
2000's | 18 (21.18) | 29.6817 |
2010's | 11 (12.94) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fort, C; Gomez-Sanchez, EP; Thwaites, D | 1 |
Betito, K; Boksa, P; Meaney, MJ; Mitchell, JB; Rowe, W | 1 |
de Caro, G; Epstein, AN; Gentili, L; Massi, M; Pompei, P | 1 |
Hu, SB; Lightman, SL; Tannahill, LA | 1 |
Gomez-Sanchez, CE; Gomez-Sanchez, EP | 1 |
Morris, DJ; Souness, GW | 2 |
Funder, JW; Myles, K; Pearce, PT; Roy, LP | 1 |
de Jong, W; de Kloet, ER; van den Berg, DT; van Dijken, HH | 1 |
Fort, CM; Gómez-Sánchez, CE; Gómez-Sánchez, EP | 1 |
Bloemers, M; de Kloet, ER; Ratka, A; Sutanto, W | 1 |
Cato, AC; Weinmann, J | 1 |
Brody, MJ; Janiak, P | 1 |
Angeli, M; Moura, AM; Worcel, M | 1 |
Epstein, AN; Massi, M | 1 |
De Kloet, ER; De Kock, S; Schild, V; Veldhuis, HD | 1 |
Epstein, AN; Nicolaïdis, S; Sakai, RR | 1 |
De Nicola, AF; Lambdin, LT; McEwen, BS; Rainbow, TC | 1 |
Bertagna, C; Corvol, P; Husson, JM; Le Go, A; Menard, J; Sassano, P; Tache, A; Ulmann, A | 1 |
Ulmann, A | 1 |
Moura, AM; Worcel, M | 1 |
Delarue, C; Deraedt, R; Leboulenger, F; Netchitailo, P; Perroteau, I; Philibert, D; Vaudry, H | 1 |
Eloy, L; Ganeval, D; Grünfeld, JP; Moura, AM; Ramos-Frendo, B; Worcel, M | 1 |
Magariños, AM; McEwen, BS; Pavlides, C; Watanabe, Y | 1 |
Funder, J; Head, G; Young, M | 1 |
Engel, JA; Eriksson, CJ; Fahlke, C; Hansen, S; Hård, E | 1 |
de Jong, W; de Kloet, ER; Van den Berg, DT | 2 |
Gómez Sánchez, EP | 1 |
Dagnault, A; Deshaies, Y; Richard, D | 2 |
de Kloet, ER; Fluttert, M; Oitzl, MS | 1 |
Rose, SP; Sandi, C | 1 |
Dean, RG; Edwards, GL; Martin, RJ; White, BD | 1 |
Josephy, M; Oitzl, MS; Spruijt, BM | 1 |
Amir, I; Shohami, E; Weidenfeld, J | 1 |
Bohus, B; de Boer, SF; de Kloet, ER; Korte, SM | 1 |
de Kloet, ER; Meijer, OC | 1 |
Bohus, B; De Kloet, ER; Koob, GF; Korte, SM; Korte-Bouws, GA | 1 |
Fahlke, C; Hansen, S; Hård, E | 1 |
Feldman, S; Itzik, A; Weidenfeld, J | 1 |
Knepper, MA; Nolan, PJ; Packer, RK | 1 |
de Kloet, ER; Oitzl, MS; van Haarst, AD | 1 |
Gómez-Sánchez, EP; Kubisch, HM; Mathialagan, S | 1 |
Cordero, MI; Sandi, C | 1 |
Cole, MA; Kalman, BA; Kim, PJ; Spencer, RL | 2 |
Johnson, JP; Latif, SA; Morris, DJ; Rokaw, MD; Watlington, CO | 1 |
Bohus, B; Buwalda, B; Douma, BR; Korte, SM; la Fleur, SE; Luiten, PG | 1 |
Khoo, K; Krozowski, ZS; Li, KX; Sheppard, KE | 1 |
Bitran, D; Dowd, JA; Dugan, MM; Renda, P; Shiekh, M | 1 |
Barthelmebs, M; De Jong, W; Imbs, JL; Rahmouni, K | 1 |
Daisley, JN; Loscertales, M; Rose, SP; Sandi, C | 1 |
Barthelmebs, M; Grima, M; Imbs, JL; Rahmouni, K | 1 |
Buwalda, B; Douma, BR; Jansen, K; Korte, SM; Luiten, PG; Van der Zee, EA | 1 |
Barthelmebs, M; De Jong, W; Grima, M; Imbs, JL; Rahmouni, K | 3 |
Fluharty, SJ; Ma, LY; McEwen, BS; Sakai, RR | 1 |
Copolov, D; Huang, W; Lee, D; Lim, AT; Wang, L | 1 |
Cole, MA; Kalman, BA; Lowrey, MJ; Pace, TW; Spencer, RL; Topczewski, F | 1 |
Deak, T; Fleshner, M; Maier, SF; Nguyen, KT; Watkins, LR | 1 |
Calvo, N; Volosin, M | 1 |
Bilang-Bleuel, A; Droste, SK; Gesing, A; Holsboer, F; Linthorst, AC; Reul, JM | 1 |
De Kloet, ER; Fluttert, MF; Sibug, RM; Van Acker, SA | 1 |
Barthelmebs, M; De Jong, W; De Kloet, ER; Grima, M; Imbs, JL; Rahmouni, K; Sibug, RM | 1 |
Funder, JW | 1 |
Benitah, JP; Bideaux, P; Gómez, AM; Kerfant, BG; Lalevee, N; Perrier, E; Richard, S; Rossier, MF | 1 |
de Kloet, ER; Holsboer, F; Levine, S; Müller, MB; Oitzl, MS; Schmidt, M; Schmidt, MV; van der Mark, M | 1 |
Pace, TW; Spencer, RL | 1 |
Dong, Q; Ge, RS; Hardy, MP; Latif, SA; Morris, DJ; Sottas, CM | 1 |
Jacobs, CM; Lømo, J; Paulsen, RE; Rootwelt, T; Trinh, MD | 1 |
de Kloet, ER; Oitzl, MS; Schächinger, H; Schwabe, L | 1 |
Wang, CC; Wang, SJ | 1 |
Dooley, R; Harvey, BJ; McEneaney, V; Thomas, W | 1 |
Chen, CC; Hsu, KS; Huang, CC; Yang, CH | 1 |
Johnson, AK; Morris, MJ; Na, ES | 1 |
McEown, K; Treit, D | 1 |
Jadavji, NM; Metz, GA; Supina, RD | 1 |
Cole, MA; Kalman, BA; Pace, TW; Spencer, RL; Ward, G | 1 |
Brocca, ME; Cymeryng, C; De Nicola, AF; Gomez-Sanchez, CE; Gomez-Sanchez, E; Lima, A; Pietranera, L; Roig, P | 1 |
Akhtar, S; Al-Rashdan, I; Babiker, F; Benter, IF; Yousif, M | 1 |
Gravenstein, N; Martynyuk, AE; Seubert, CN; Sumners, C; Tan, S; Vasilopoulos, T; Xu, C; Zhang, J | 1 |
Gravenstein, N; Martynyuk, AE; Puentes, DL; Seubert, CN; Xu, C; Zhang, J | 1 |
Aedo, JE; Espinoza, MB; Molina, A; Valdés, JA; Valenzuela, C; Zuloaga, R | 1 |
1 review(s) available for spironolactone and ru 28318
Article | Year |
---|---|
[Aldosterone antagonists: hypotensive and natriuretic drugs].
Topics: Humans; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Spironolactone | 1985 |
1 trial(s) available for spironolactone and ru 28318
Article | Year |
---|---|
Assessment of the antimineralocorticoid effect of RU 28318 in healthy men with induced exogenous and endogenous hypermineralocorticism.
Topics: Adult; Aldosterone; Clinical Trials as Topic; Double-Blind Method; Fludrocortisone; Furosemide; Humans; Hyperaldosteronism; Male; Mineralocorticoid Receptor Antagonists; Potassium; Sodium; Spironolactone; Time Factors | 1985 |
83 other study(ies) available for spironolactone and ru 28318
Article | Year |
---|---|
Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats.
Topics: Animals; Blood Pressure; Brain; Diet; Female; Hypertension; Injections, Intraventricular; Male; Mineralocorticoids; Rats; Rats, Mutant Strains; Receptors, Mineralocorticoid; Receptors, Steroid; Sodium Chloride; Spironolactone | 1992 |
Serotonergic regulation of type II corticosteroid receptor binding in hippocampal cell cultures: evidence for the importance of serotonin-induced changes in cAMP levels.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amphetamines; Animals; Cells, Cultured; Cyclic AMP; Female; Hippocampus; Mineralocorticoid Receptor Antagonists; Piperazines; Pregnancy; Rats; Receptors, Glucocorticoid; Second Messenger Systems; Serotonin; Serotonin Antagonists; Spironolactone | 1992 |
Central tachykinin injection potently suppresses the need-free salt intake of the female rat.
Topics: Aldosterone; Angiotensin II; Animals; Captopril; Down-Regulation; Drinking; Eating; Eledoisin; Female; Injections, Intraperitoneal; Injections, Intraventricular; Kassinin; Mineralocorticoid Receptor Antagonists; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Tachykinin; Sodium, Dietary; Spironolactone; Sucrose; Tachykinins | 1992 |
Dexamethasone and aldosterone modulate corticotropin-releasing factor-41 release from cultured rat fetal hypothalamic cells through type II and type I corticosteroid receptors respectively.
Topics: Aldosterone; Animals; Cells, Cultured; Colforsin; Corticotropin-Releasing Hormone; Dexamethasone; Fetus; Hypothalamus; Mifepristone; Mineralocorticoid Receptor Antagonists; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Spironolactone | 1992 |
Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone.
Topics: Administration, Oral; Animals; Blood Pressure; Brain; Carbenoxolone; Corticosterone; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hypertension; Injections, Intraventricular; Male; Rats; Rats, Sprague-Dawley; Spironolactone | 1992 |
The "mineralocorticoid-like" actions conferred on corticosterone by carbenoxolone are inhibited by the mineralocorticoid receptor (type I) antagonist RU28318.
Topics: Adrenalectomy; Aldosterone; Animals; Carbenoxolone; Corticosterone; Creatinine; Desoxycorticosterone; Male; Mineralocorticoids; Natriuresis; Potassium; Rats; Receptors, Mineralocorticoid; Receptors, Steroid; Spironolactone | 1991 |
Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: toward a redefinition of mineralocorticoid action.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adrenalectomy; Aldosterone; Androstanols; Animals; Bicarbonates; Carbenoxolone; Child; Electrolytes; Female; Humans; Hydrocortisone; Hydroxysteroid Dehydrogenases; Male; Mifepristone; Mineralocorticoids; Natriuresis; Pseudohypoaldosteronism; Rats; Rats, Inbred Strains; Receptors, Mineralocorticoid; Receptors, Steroid; Spironolactone | 1990 |
Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
Topics: Adrenalectomy; Aldosterone; Androstanols; Animals; Blood Pressure; Brain; Corticosterone; Glucocorticoids; Injections, Intraventricular; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Rats; Rats, Inbred Strains; Spironolactone | 1990 |
Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension.
Topics: Aldosterone; Animals; Blood Pressure; Cerebral Ventricles; Hypertension; Infusions, Parenteral; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Inbred Strains; Reference Values; Sodium, Dietary; Spironolactone | 1990 |
On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation.
Topics: Animals; Brain; Corticosterone; Estrenes; Glucocorticoids; Injections, Intraventricular; Injections, Subcutaneous; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Steroid; Spironolactone; Stress, Physiological | 1989 |
Mineralocorticoid regulation of transcription of transfected mouse mammary tumor virus DNA in cultured kidney cells.
Topics: Aldosterone; Animals; Cats; Cell Line; DNA, Viral; Gene Expression Regulation; Kidney; Mammary Tumor Virus, Mouse; Receptors, Mineralocorticoid; Receptors, Steroid; Regulatory Sequences, Nucleic Acid; Spironolactone; Structure-Activity Relationship; Transcription, Genetic | 1988 |
Central interactions between aldosterone and vasopressin on cardiovascular system.
Topics: Aldosterone; Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Carbachol; Cardiovascular System; Drug Interactions; Heart Rate; Male; Phenylephrine; Rats; Rats, Inbred Strains; Receptors, Mineralocorticoid; Receptors, Steroid; Spironolactone; Vasopressins | 1988 |
Extrarenal effects of aldosterone and antimineralocorticoid compounds.
Topics: Aldosterone; Animals; Biological Transport, Active; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Potassium Channels; Rats; Rats, Inbred Strains; Sodium Channels; Spironolactone; Vasopressins | 1988 |
The apparent dependence of salt appetite in the pigeon on endogenous angiotensin II.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Animals; Appetite; Captopril; Columbidae; Drinking; Male; Receptors, Angiotensin; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Sodium; Sodium Chloride; Spironolactone | 1987 |
Antiglucocorticoid RU 38486 attenuates retention of a behaviour and disinhibits the hypothalamic-pituitary adrenal axis at different brain sites.
Topics: Adrenalectomy; Animals; Behavior, Animal; Brain; Corticosterone; Dexamethasone; Dose-Response Relationship, Drug; Estrenes; Hypothalamo-Hypophyseal System; Injections, Intraventricular; Male; Memory; Mifepristone; Pituitary-Adrenal System; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid; Retention, Psychology; Spironolactone | 1988 |
Salt appetite is suppressed by interference with angiotensin II and aldosterone.
Topics: Aldosterone; Angiotensin II; Animals; Appetite; Captopril; Cerebral Ventricles; Insulin; Male; Natriuresis; Rats; Rats, Inbred Strains; Sodium Chloride; Spironolactone | 1986 |
Aldosterone effects on salt appetite in adrenalectomized rats.
Topics: Adrenalectomy; Aldosterone; Animals; Appetite; Brain Chemistry; Corticosterone; Drinking Behavior; Drug Interactions; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Inbred Strains; Sodium Chloride; Spironolactone | 1986 |
[Effects of RU 28318 on 22Na and 86Rb efflux from arterial smooth muscle].
Topics: Animals; Male; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Rats; Rubidium; Sodium; Spironolactone | 1985 |
The effect of the antimineralocorticoid RU 28318 on aldosterone biosynthesis in vitro.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Kinetics; Rana ridibunda; Spironolactone; Time Factors | 1984 |
[Effect of an antiglucocorticoid steroid on the arterial hypertension induced by glucocorticoids in the rat].
Topics: Androstanols; Animals; Blood Pressure; Estrenes; Glucocorticoids; Hypertension; Male; Mifepristone; Mineralocorticoids; Rats; Rats, Inbred Strains; Sodium; Spironolactone | 1984 |
Opposing roles of type I and type II adrenal steroid receptors in hippocampal long-term potentiation.
Topics: Adrenal Cortex Hormones; Adrenalectomy; Aldosterone; Animals; Corticosterone; Dentate Gyrus; Electric Stimulation; Hippocampus; Hormone Antagonists; Long-Term Potentiation; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Neural Pathways; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Steroid; Spironolactone | 1995 |
Determinants of cardiac fibrosis in experimental hypermineralocorticoid states.
Topics: Adrenalectomy; Aldosterone; Animals; Desoxycorticosterone; Drug Combinations; Fibrosis; Fludrocortisone; Heart; Hormone Antagonists; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Myocardium; Nephrectomy; Potassium; Rats; Rats, Sprague-Dawley; Spironolactone | 1995 |
Consequence of long-term exposure to corticosterone or dexamethasone on ethanol consumption in the adrenalectomized rat, and the effect of type I and type II corticosteroid receptor antagonists.
Topics: Adrenalectomy; Alcohol Drinking; Animals; Body Weight; Corticosterone; Dexamethasone; Drinking; Drug Implants; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Organ Size; Rats; Rats, Wistar; Receptors, Steroid; Sodium Chloride; Spironolactone | 1995 |
Mineralocorticoid antagonist inhibits stress-induced blood pressure response after repeated daily warming.
Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Blood Pressure; Corticosterone; Heart Rate; Hot Temperature; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Wistar; Spironolactone; Stress, Physiological | 1994 |
Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats.
Topics: Animals; Blood Pressure; Brain; Desoxycorticosterone; Heart Rate; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Wistar; Receptors, Mineralocorticoid; Sodium Chloride; Spironolactone | 1994 |
Hypertension and the mineralocorticoid receptor in the brain.
Topics: Adrenalectomy; Aldosterone; Amiloride; Animals; Blood Pressure; Brain; Cerebral Ventricles; Hippocampus; Hypertension; Infusions, Parenteral; Mineralocorticoid Receptor Antagonists; Rats; Receptors, Mineralocorticoid; Spironolactone | 1994 |
The effects of RU 38486 and RU 28318 on energy balance of ovariectomized rats.
Topics: Analysis of Variance; Animals; Energy Metabolism; Female; Mifepristone; Mineralocorticoid Receptor Antagonists; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Reference Values; Spironolactone | 1994 |
The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticosteroid receptors.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Animals; Corticosterone; Exploratory Behavior; Locomotion; Male; Mifepristone; Rats; Rats, Wistar; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spatial Behavior; Spironolactone | 1994 |
Corticosteroid receptor antagonists are amnestic for passive avoidance learning in day-old chicks.
Topics: Amnesia; Animals; Animals, Newborn; Avoidance Learning; Brain; Chickens; Female; Injections; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Neuronal Plasticity; Receptors, Glucocorticoid; Receptors, Steroid; Spironolactone | 1994 |
Type II corticosteroid receptor stimulation increases NPY gene expression in basomedial hypothalamus of rats.
Topics: Adrenalectomy; Aldosterone; Androstanols; Animals; Blood Glucose; Drug Interactions; Gene Expression Regulation; Hypothalamus, Middle; Infusions, Parenteral; Insulin; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Steroid; RNA, Messenger; Spironolactone | 1994 |
An ACTH/MSH(4-9) analog counteracts the behavioral effects of a mineralocorticoid receptor antagonist.
Topics: Adrenocorticotropic Hormone; Analysis of Variance; Animals; Avoidance Learning; Male; Mineralocorticoids; Peptide Fragments; Rats; Rats, Wistar; Receptors, Mineralocorticoid; Receptors, Steroid; Spatial Behavior; Spironolactone | 1993 |
11-Dehydrocorticosterone in the presence of carbenoxolone is a more potent sodium retainer than corticosterone.
Topics: Adrenalectomy; Animals; Carbenoxolone; Corticosterone; Creatinine; Male; Mineralocorticoid Receptor Antagonists; Natriuresis; Potassium; Rats; Rats, Sprague-Dawley; Spironolactone | 1993 |
Role of glucocorticoids in the regulation of brain prostaglandin biosynthesis under basal conditions and in response to endotoxin.
Topics: Adrenalectomy; Animals; Cerebral Cortex; Cerebral Ventricles; Dexamethasone; Dinoprostone; In Vitro Techniques; Injections, Intraventricular; Lipopolysaccharides; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Rats; Rats, Inbred Strains; Reference Values; Spironolactone | 1993 |
Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze.
Topics: Animals; Anxiety; Behavior, Animal; Fear; Injections, Intraventricular; Male; Maze Learning; Mifepristone; Mineralocorticoid Receptor Antagonists; Rats; Rats, Wistar; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone; Stress, Physiological | 1995 |
A role for the mineralocorticoid receptor in a rapid and transient suppression of hippocampal 5-HT1A receptor mRNA by corticosterone.
Topics: Adrenalectomy; Animals; Corticosterone; Densitometry; Dose-Response Relationship, Drug; Gene Expression Regulation; Hippocampus; In Situ Hybridization; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Rats; Rats, Wistar; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Serotonin; RNA, Messenger; Spironolactone | 1995 |
Mineralocorticoid and glucocorticoid receptor antagonists in animal models of anxiety.
Topics: Acoustic Stimulation; Animals; Anxiety; Behavior, Animal; Electroshock; Fear; Hormone Antagonists; Injections, Intraventricular; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Motor Activity; Rats; Rats, Wistar; Receptors, Glucocorticoid; Reflex, Startle; Spironolactone | 1996 |
Involvement of type I corticosteroid receptor in the effects of ovariectomy on energy balance.
Topics: Animals; Body Weight; Energy Metabolism; Female; Lipid Metabolism; Mifepristone; Mineralocorticoid Receptor Antagonists; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone | 1996 |
Facilitation of ethanol consumption by intracerebroventricular infusions of corticosterone.
Topics: Adrenalectomy; Alcohol Drinking; Animals; Corticosterone; Drinking; Injections, Intraventricular; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Rats; Rats, Wistar; Receptors, Glucocorticoid; Spironolactone | 1996 |
Effect of glucocorticoids on the adrenocortical axis responses to electrical stimulation of the amygdala and the ventral noradrenergic bundle.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Amygdala; Animals; Corticosterone; Corticotropin-Releasing Hormone; Dexamethasone; Electric Stimulation; Feedback; Hypothalamo-Hypophyseal System; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Pituitary-Adrenal System; Rats; Rats, Inbred Strains; Spironolactone | 1997 |
Role of adrenal steroids in stimulating ammonium excretion during acute metabolic acidosis.
Topics: Acidosis; Adrenal Cortex Hormones; Adrenal Glands; Ammonium Chloride; Animals; Corticosterone; Hormone Antagonists; Hydrogen-Ion Concentration; Hydroxysteroid Dehydrogenases; Kidney Tubules, Collecting; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Spironolactone; Steroids | 1997 |
Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus.
Topics: Adrenocorticotropic Hormone; Animals; Circadian Rhythm; Corticosterone; Feedback; Hippocampus; Hypothalamus; Injections, Intraventricular; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Pituitary-Adrenal System; Rats; Rats, Wistar; Receptors, Glucocorticoid; Spironolactone | 1997 |
Modulation of blood pressure in the Dahl SS/jr rat by embryo transfer.
Topics: Adult; Aging; Animals; Blood Pressure; Cerebral Ventricles; Embryo Transfer; Female; Genotype; Humans; Infusions, Parenteral; Male; Mineralocorticoid Receptor Antagonists; Pregnancy; Rats; Rats, Inbred Strains; Sex Characteristics; Spironolactone | 1998 |
A role for brain glucocorticoid receptors in contextual fear conditioning: dependence upon training intensity.
Topics: Animals; Brain; Conditioning, Psychological; Corticosterone; Electroshock; Fear; Hormone Antagonists; Injections, Intraventricular; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Rats; Rats, Wistar; Receptors, Glucocorticoid; Spironolactone | 1998 |
Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity.
Topics: Adrenocorticotropic Hormone; Animals; Circadian Rhythm; Corticosterone; Drug Combinations; Hormone Antagonists; Hypothalamo-Hypophyseal System; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Steroid; Spironolactone | 1998 |
A second enzyme protecting mineralocorticoid receptors from glucocorticoid occupancy.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Animals; Aryl Hydrocarbon Hydroxylases; Cell Line; Corticosterone; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Electric Conductivity; Glucocorticoids; Hydroxysteroid Dehydrogenases; Isoenzymes; Kidney; Macrolides; Mineralocorticoid Receptor Antagonists; Oxidoreductases, N-Demethylating; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone; Steroid Hydroxylases; Xenopus laevis | 1998 |
Repeated blockade of mineralocorticoid receptors, but not of glucocorticoid receptors impairs food rewarded spatial learning.
Topics: Animals; Corticosterone; Food; Hippocampus; Hormone Antagonists; Male; Maze Learning; Mifepristone; Mineralocorticoid Receptor Antagonists; Rats; Rats, Wistar; Receptors, Glucocorticoid; Reward; Space Perception; Spironolactone | 1998 |
Steroid specificity of the putative DHB receptor: evidence that the receptor is not 11betaHSD.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Animals; Carbenoxolone; Cell Nucleus; Cells, Cultured; CHO Cells; Colon; Corticosterone; Cricetinae; Culture Media, Conditioned; Hydroxysteroid Dehydrogenases; Intestinal Mucosa; Male; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Spironolactone; Substrate Specificity; Transfection | 1998 |
Corticosterone is permissive to the anxiolytic effect that results from the blockade of hippocampal mineralocorticoid receptors.
Topics: Adrenalectomy; Animals; Anti-Anxiety Agents; Anti-Inflammatory Agents; Anxiety; Corticosterone; Cortisone; Dexamethasone; Hippocampus; Male; Microinjections; Mifepristone; Mineralocorticoid Receptor Antagonists; Rats; Receptors, Glucocorticoid; Spironolactone | 1998 |
[Brain mineralocorticoid receptor and blood pressure control in the conscious normotensive rat].
Topics: Animals; Blood Pressure; Brain; Female; Hypertension; Kidney; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Wistar; Receptors, Mineralocorticoid; Spironolactone | 1998 |
Piracetam facilitates long-term memory for a passive avoidance task in chicks through a mechanism that requires a brain corticosteroid action.
Topics: Adrenal Cortex Hormones; Animals; Animals, Newborn; Avoidance Learning; Brain; Chickens; Corticosterone; Female; Hormone Antagonists; Male; Memory; Mifepristone; Mineralocorticoid Receptor Antagonists; Nootropic Agents; Piracetam; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone | 1998 |
Evaluation of RU28318 and RU40555 as selective mineralocorticoid receptor and glucocorticoid receptor antagonists, respectively: receptor measures and functional studies.
Topics: Adrenalectomy; Animals; Biological Assay; Corticosterone; Dexamethasone; Hippocampus; Hormone Antagonists; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Pituitary Gland; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone | 1998 |
Brain mineralocorticoid receptor control of blood pressure and kidney function in normotensive rats.
Topics: Animals; Blood Pressure; Brain; Chlorides; Data Interpretation, Statistical; Denervation; Diuresis; Homeostasis; Injections, Subcutaneous; Kidney; Male; Mineralocorticoid Receptor Antagonists; Potassium; Rats; Rats, Wistar; Receptors, Mineralocorticoid; Renin; Sodium; Spironolactone; Time Factors | 1999 |
Corticosterone modifies muscarinic receptor immunoreactivity in rat hippocampus.
Topics: Acetylcholine; Adrenalectomy; Animals; Corticosterone; Hippocampus; Immunohistochemistry; Male; Mifepristone; Rats; Rats, Wistar; Receptors, Muscarinic; Spironolactone | 1999 |
Cardiovascular and renal effects of central administration of a mineralocorticoid receptor antagonist in conscious female rats.
Topics: Animals; Blood Pressure; Cardiovascular Physiological Phenomena; Chlorides; Consciousness; Female; Heart Rate; Injections, Intraventricular; Kidney; Male; Mineralocorticoid Receptor Antagonists; Potassium; Rats; Rats, Wistar; Sodium; Spironolactone; Systole; Urination | 1999 |
The amygdala: site of genomic and nongenomic arousal of aldosterone-induced sodium intake.
Topics: Aldosterone; Amygdala; Animals; Appetite; Arousal; Corticosterone; Desoxycorticosterone; Genome; Hormone Antagonists; Injections; Injections, Intraventricular; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Oligonucleotides, Antisense; Rats; Rats, Sprague-Dawley; Receptors, GABA; Receptors, Mineralocorticoid; Sodium; Spironolactone | 2000 |
Glucocorticoid modulation of dopamine mediated effects on hypothalamic atrial natriuretic factor neurons.
Topics: Animals; Animals, Newborn; Atrial Natriuretic Factor; Cells, Cultured; Desoxycorticosterone; Dexamethasone; Dopamine; Down-Regulation; Gene Expression Regulation; Glucocorticoids; Hypothalamus; Mifepristone; Neurons; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Spironolactone; Transcription, Genetic | 2000 |
Selective blockade of the mineralocorticoid receptor impairs hypothalamic-pituitary-adrenal axis expression of habituation.
Topics: Animals; Corticosterone; Drug Combinations; Habituation, Psychophysiologic; Hormone Antagonists; Hypothalamo-Hypophyseal System; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Restraint, Physical; Spironolactone; Stress, Physiological | 2000 |
Endogenous glucocorticoids play a positive regulatory role in the anti-keyhole limpet hemocyanin in vivo antibody response.
Topics: Administration, Oral; Adrenalectomy; Animals; Antigens; Corticosterone; Dexamethasone; Drug Combinations; Hemocyanins; Hormone Antagonists; Hypertrophy; Immunoglobulin G; Immunoglobulin Isotypes; Immunoglobulin M; Immunosuppressive Agents; Injections, Intraperitoneal; Injections, Subcutaneous; Interferon-gamma; Male; Mifepristone; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Spironolactone; Spleen; Thymus Gland | 2001 |
Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint.
Topics: Adrenalectomy; Animals; Anti-Inflammatory Agents; Anxiety; Corticosterone; Dexamethasone; Injections, Intraventricular; Male; Metyrapone; Mifepristone; Mineralocorticoid Receptor Antagonists; Rats; Rats, Wistar; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Restraint, Physical; Spironolactone; Stress, Psychological | 2001 |
Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone.
Topics: Adrenalectomy; Animals; Cold Temperature; Corticosterone; Corticotropin-Releasing Hormone; Dexamethasone; Environment; Glucocorticoids; Hippocampus; Hypothalamo-Hypophyseal System; Immunohistochemistry; Injections, Intraventricular; Male; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Pituitary-Adrenal System; Pyramidal Cells; Radioligand Assay; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone; Stress, Psychological; Swimming | 2001 |
Involvement of brain mineralocorticoid receptor in salt-enhanced hypertension in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Brain; Denervation; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Injections, Intraventricular; Kidney; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Mineralocorticoid; Sodium, Dietary; Spironolactone; Time Factors | 2001 |
Intracerebroventricular administration of a glucocorticoid receptor antagonist enhances the cardiovascular responses to brief restraint stress.
Topics: Animals; Blood Pressure; Circadian Rhythm; Heart Rate; Hot Temperature; Injections, Intraventricular; Male; Mifepristone; Rats; Rats, Wistar; Receptors, Glucocorticoid; Restraint, Physical; Spironolactone; Stress, Physiological; Time Factors | 2001 |
Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
Topics: Angiotensinogen; Animals; Atrial Natriuretic Factor; Blood Pressure; Brain; Chlorides; Desoxycorticosterone; Diuresis; Hypertension; Injections, Intraventricular; Kidney; Male; Mineralocorticoid Receptor Antagonists; Potassium; Rats; Rats, Wistar; Receptors, Mineralocorticoid; RNA, Messenger; Sodium; Sodium Chloride, Dietary; Spironolactone; Time Factors; Transcription, Genetic | 2002 |
Central effects of mineralocorticoids on blood pressure: new answers, new questions.
Topics: Animals; Blood Pressure; Brain; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Rats; Spironolactone | 2002 |
Influence of sodium intake on the cardiovascular and renal effects of brain mineralocorticoid receptor blockade in normotensive rats.
Topics: Animals; Blood Pressure; Cardiovascular System; Chlorides; Diet, Sodium-Restricted; Diuresis; Heart Rate; Injections, Intraventricular; Male; Mineralocorticoid Receptor Antagonists; Potassium; Rats; Rats, Wistar; Renin; Spironolactone; Systole | 2002 |
Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction.
Topics: Action Potentials; Animals; Aorta, Abdominal; Aortic Valve Stenosis; Calcium; Calcium Channels, L-Type; Heart Conduction System; Hormone Antagonists; Hypertrophy, Left Ventricular; Ion Transport; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium; Potassium Channels, Voltage-Gated; Rats; Rats, Wistar; Receptors, Mineralocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Shal Potassium Channels; Spironolactone | 2004 |
Glucocorticoid receptor blockade disinhibits pituitary-adrenal activity during the stress hyporesponsive period of the mouse.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Animals, Newborn; Corticosterone; Hippocampus; Hypothalamus; In Situ Hybridization; Mice; Mineralocorticoid Receptor Antagonists; Pituitary Gland, Anterior; Pro-Opiomelanocortin; Receptors, Glucocorticoid; RNA, Messenger; Spironolactone; Temperature; Time Factors | 2005 |
Disruption of mineralocorticoid receptor function increases corticosterone responding to a mild, but not moderate, psychological stressor.
Topics: Adrenalectomy; Animals; Corticosterone; Handling, Psychological; Hypothalamo-Hypophyseal System; Male; Mineralocorticoid Receptor Antagonists; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Restraint, Physical; Spironolactone; Stress, Physiological | 2005 |
Stimulation of testosterone production in rat Leydig cells by aldosterone is mineralocorticoid receptor mediated.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Animals; Binding Sites; Carbenoxolone; Corticosterone; Drug Synergism; In Vitro Techniques; Leydig Cells; Male; Mineralocorticoid Receptor Antagonists; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Testosterone | 2005 |
Dexamethasone induces cell death which may be blocked by NMDA receptor antagonists but is insensitive to Mg2+ in cerebellar granule neurons.
Topics: Animals; Biological Transport; Cell Death; Cells, Cultured; Cerebellum; Dexamethasone; Excitatory Amino Acid Agonists; Magnesium; Mineralocorticoid Receptor Antagonists; Mitochondria; Nerve Growth Factor; Neurons; Rats; Receptors, N-Methyl-D-Aspartate; Spironolactone | 2006 |
Corticosteroids operate as a switch between memory systems.
Topics: Animals; Caudate Nucleus; Corticosterone; Hippocampus; Memory; Mice; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Receptors, Mineralocorticoid; Spironolactone; Stress, Physiological | 2010 |
Modulation of presynaptic glucocorticoid receptors on glutamate release from rat hippocampal nerve terminals.
Topics: 4-Aminopyridine; Adrenalectomy; Animals; Cortisone; Dexamethasone; Down-Regulation; Drug Administration Schedule; Glucocorticoids; Glutamic Acid; Hippocampus; Male; Mifepristone; Potassium Channel Blockers; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Spironolactone; Synaptic Membranes; Synaptic Transmission; Synaptosomes | 2009 |
Protein kinase D stabilizes aldosterone-induced ERK1/2 MAP kinase activation in M1 renal cortical collecting duct cells to promote cell proliferation.
Topics: Acetophenones; Active Transport, Cell Nucleus; Aldosterone; Animals; Benzopyrans; Cell Line; Cell Proliferation; Cytoplasm; Enzyme Activation; Epithelial Cells; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Kidney Cortex; Kidney Tubules, Collecting; Mice; Mineralocorticoid Receptor Antagonists; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Biological; Phosphorylation; Protein Binding; Protein Kinase C-delta; Protein Kinase Inhibitors; Quinazolines; Receptors, Mineralocorticoid; Signal Transduction; Spironolactone; TRPP Cation Channels; Tyrphostins | 2010 |
Acute stress impairs hippocampal mossy fiber-CA3 long-term potentiation by enhancing cAMP-specific phosphodiesterase 4 activity.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adrenalectomy; Animals; Anti-Inflammatory Agents; Biophysical Phenomena; Colforsin; Corticosterone; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Electric Stimulation; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Mossy Fibers, Hippocampal; Phosphodiesterase Inhibitors; Spironolactone; Stress, Psychological; Synaptosomes; Xanthines | 2010 |
Mineralocorticoid receptor antagonism prevents hedonic deficits induced by a chronic sodium appetite.
Topics: Aldosterone; Animals; Appetite; Captopril; Desoxycorticosterone; Drug Interactions; Furosemide; Hyponatremia; Hypothalamic Area, Lateral; Injections, Intraventricular; Male; Mineralocorticoid Receptor Antagonists; Potassium; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Renin; Renin-Angiotensin System; Reward; Self Stimulation; Sodium; Spironolactone | 2010 |
Mineralocorticoid receptors in the medial prefrontal cortex and hippocampus mediate rats' unconditioned fear behaviour.
Topics: Animals; Behavior, Animal; Conditioning, Psychological; Fear; Hippocampus; Male; Maze Learning; Mineralocorticoid Receptor Antagonists; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Spironolactone | 2011 |
Blockade of mineralocorticoid and glucocorticoid receptors reverses stress-induced motor impairments.
Topics: Aldosterone; Animals; Blood Glucose; Corticosterone; Dexamethasone; Female; Hormone Antagonists; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Motor Activity; Motor Skills; Rats; Receptors, Glucocorticoid; Restraint, Physical; Spironolactone; Stress, Physiological | 2011 |
Acute exposure to a novel stressor further reduces the habituated corticosterone response to restraint in rats.
Topics: Animals; Behavior, Animal; Corticosterone; Feedback, Physiological; Habituation, Psychophysiologic; Hormone Antagonists; Hypothalamo-Hypophyseal System; Injections; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Restraint, Physical; Spironolactone; Stress, Psychological; Time Factors | 2001 |
Increased expression of the mineralocorticoid receptor in the brain of spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Hippocampus; Hypothalamus; Mineralocorticoid Receptor Antagonists; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone | 2012 |
RU28318, an aldosterone antagonist, in combination with an ACE inhibitor and angiotensin receptor blocker attenuates cardiac dysfunction in diabetes.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Heart; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Spironolactone | 2013 |
Anesthesia with sevoflurane in neonatal rats: Developmental neuroendocrine abnormalities and alleviating effects of the corticosteroid and Cl(-) importer antagonists.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Animals, Newborn; Anxiety; Bumetanide; CA1 Region, Hippocampal; Chloride Channels; Corticosterone; Excitatory Postsynaptic Potentials; Female; Male; Maternal Deprivation; Methyl Ethers; Neurosecretory Systems; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Reflex, Startle; Sevoflurane; Sex Characteristics; Spironolactone | 2015 |
Role of Steroids in Hyperexcitatory Adverse and Anesthetic Effects of Sevoflurane in Neonatal Rats.
Topics: Anesthetics; Animals; Animals, Newborn; Brain Waves; Bumetanide; Drug Interactions; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; Hippocampus; In Vitro Techniques; Male; Membrane Potentials; Methyl Ethers; Rats; Rats, Sprague-Dawley; Reaction Time; Reflex, Righting; Sevoflurane; Sodium Potassium Chloride Symporter Inhibitors; Spironolactone; Steroids | 2016 |
Cortisol Induces Reactive Oxygen Species Through a Membrane Glucocorticoid Receptor in Rainbow Trout Myotubes.
Topics: Animals; Cyclic AMP Response Element-Binding Protein; Fish Proteins; Hormone Antagonists; Hydrocortisone; MAP Kinase Signaling System; Mifepristone; Models, Biological; Muscle Fibers, Skeletal; Oncorhynchus mykiss; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Reactive Oxygen Species; Receptors, Glucocorticoid; Spironolactone; Stress, Physiological | 2017 |